Product image of Zevalin (Ibritumomab Tiuxetan) supplied by GNH India

Zevalin

Active Ingredient:
Ibritumomab Tiuxetan
Origin:
EU

Zevalin (Ibritumomab Tiuxetan)

Zevalin (ibritumomab tiuxetan) is an intravenous radioimmunotherapy medication used for certain types of non-Hodgkin lymphoma. This targeted therapy combines a monoclonal antibody with a radioactive isotope to treat cancer. Always consult a healthcare provider for personalized guidance.

Manufacturer / TM Owner

Ceft Biopharma S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zevalin is primarily used to treat non-Hodgkin lymphoma, a type of cancer affecting the lymphatic system. It is indicated for patients with relapsed or refractory low-grade, follicular, or transformed B-cell lymphomas. The therapy targets CD20-positive B-cells, helping to reduce cancerous cells in the body. Patients often ask, 'what is Zevalin used for' when exploring treatment options.

Side Effects

  • Zevalin works by delivering radiation directly to cancerous B-cells while sparing healthy tissues. Patients may experience effects such as fatigue, nausea, or low blood cell counts as the body responds to treatment. These effects vary depending on individual health conditions and treatment protocols. Monitoring by a healthcare provider is essential during therapy.

Precautions & Warnings

  • Zevalin should only be administered under the supervision of a qualified healthcare professional in a controlled medical setting. Patients must undergo thorough screening to ensure suitability for radioimmunotherapy. Hydration and infection prevention measures may be recommended before and after treatment. Always disclose your full medical history to your provider.

Avoid Interactions

  • Zevalin may interact with other medications affecting the immune system or blood cell counts, such as immunosuppressants or chemotherapy drugs. Live vaccines should be avoided during and after treatment due to potential risks. Patients should inform their healthcare provider about all medications, including over-the-counter and herbal supplements. Alcohol use may exacerbate certain side effects.

Frequently Asked Questions

Zevalin is used to treat certain types of non-Hodgkin lymphoma, including relapsed or refractory B-cell lymphomas.

Zevalin is given as an intravenous infusion in a healthcare setting, typically over several hours.

Common side effects may include fatigue, nausea, and low blood cell counts, which should be monitored by a healthcare provider.

Zevalin may interact with other medications, so your healthcare provider will determine if it is suitable alongside other therapies.

Zevalin may harm an unborn baby; discuss contraception and pregnancy plans with your healthcare provider before treatment.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ibritumomab Tiuxetan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT